Sign Up

Makers of obesity drugs hit back at claims of negative side effects

Financial Times 1 min read 13 hours ago

Novo and Eli Lilly respond to concerns that their blockbuster GLP-1 medicines can lead to problems including poor nutrition
Read original Financial Times

More from Financial Times

US air travel chaos exposes system held together by ‘string and duct tape’
Passengers face widespread disruption after US air traffic control outage
Nvidia exposed to possible lawsuits after Jensen Huang’s downfall
Germany suffers setback in joining fighter jet project

Related in Business

US air travel chaos exposes system held together by ‘string and duct tape’
Passengers face widespread disruption after US air traffic control outage
Nvidia exposed to possible lawsuits after Jensen Huang’s downfall
Germany suffers setback in joining fighter jet project